ADITUM BIO
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.
ADITUM BIO
Social Links:
Industry:
Health Care Medical Therapeutics Venture Capital
Founded:
2019-01-01
Status:
Active
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-15 | Anteris Bio | Anteris Bio acquired by Aditum Bio | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-08 | Hubpay | Aditum Bio investment in Series A - Hubpay | 20 M USD |
| 2021-09-07 | Via Nova Therapeutics | Aditum Bio investment in Series A - Via Nova Therapeutics | 20 M USD |
| 2021-08-31 | Versanis Bio | Aditum Bio investment in Series A - Versanis Bio | 70 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-08 | Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio |
More informations about "Aditum Bio"
About | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio brings together unmatched scientific and domain expertise with agile operational capabilities. Our unique investment and operating model enables rapid company formation, …See details»
Aditum Bio - Crunchbase Investor Profile & Investments
Aditum Bio was founded on 2019 and is headquartered in San Francisco, California. Lists Featuring This Company. Edit Lists Featuring This Company Section. West Coast Female …See details»
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio …
Nov 7, 2024 OAKLAND and NANJING, NOVEMBER 7, 2024 [PR NEWSWIRE] – Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being formed in …See details»
Aditum Bio and Leads Biolabs join forces to fight autoimmune …
Nov 7, 2024 Under the terms of the agreement, Aditum Bio will fund Oblenio Bio, while Leads Biolabs will allow the new company to develop, globally manufacture and commercialize LBL …See details»
VC Aditum Bio hatches autoimmune-focused Oblenio Bio with …
Nov 7, 2024 In 2023, Aditum’s weight loss biotech Versanis Bio sold to Eli Lilly for up to $1.92 billion in upfront payments and potential milestones. Versanis’ lead asset, an antibody called …See details»
Aditum Bio investment portfolio - PitchBook
Aditum Bio's latest investment was on 08-May-2023 in Vitalli Bio, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure you’re getting the most accurate …See details»
People | Aditum Bio | Biotechnology Assets to Benefit …
Aditum Bio has brought together a renowned, highly credentialed leadership team with the vision, expertise, and ambition to deliver on the promise of our new model of biotech venture capital.See details»
Novartis alums Jimenez, Fishman unveil their next act: …
Nov 2, 2020 Aditum’s first spinout, Teres Bio, is working on treatments for atopic dermatitis and plaque psoriasis, while its second, Tempero Bio, is developing a drug licensed from Sosei Heptares for ...See details»
Novartis alums Jimenez, Fishman unveil their next act: …
Nov 3, 2020 Now, he’s unveiling that something: Aditum Bio, a biotech investment firm he co-founded with Mark Fishman, M.D., former president of the Novartis Institutes for BioMedical Research. The duo set up shop in 2019 but …See details»
Aditum Bio Announces Formation of Celexor Bio, Focused on
Sep 21, 2023 Celexor Bio is the tenth company formed by Aditum Bio. OAKLAND, Calif. , Sept. 21, 2023 /PRNewswire/ -- Aditum Bio, the biotech investment firm cofounded in 2019 by …See details»
Aditum Bio Announces Formation of Third Company, Anteris Bio
Dec 15, 2020 Aditum Bio focuses on basic mechanisms of disease, in-licenses promising drug candidates directed at such pathophysiologies, and spins-out individual companies dedicated …See details»
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio …
Nov 7, 2024 Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreement to develop LBL …See details»
Immagene, Aditum Bio Partner to Create New Biotech Company
Sep 21, 2023 Immagene Biopharmaceuticals and Aditum Bio have announced a joint venture to create Celexor Bio, a new biotech company focused on cell depletion of pathologic cells in …See details»
Portfolio | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio is harnessing our unique investment approach focused on the translational stage of drug development, combined with our agile operating model for company formation and trial …See details»
Aditum Bio - Investments, Portfolio & Company Exits - Crunchbase
Aditum Bio has acquired Anteris Bio on Dec 15, 2020. Unlock for free . Investments. Edit Investments Section. Number of Investments 3. ... Which industries has this organization had …See details»
Aditum Bio Announces Formation of Third Company, Anteris Bio
Dec 15, 2020 About Aditum Bio Aditum Bio is committed to improving public health by accelerating R&D in disease areas with both large and more targeted patient populations, …See details»
Approach | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio’s strategic advantage extends to its proven acumen for using an array of powerful technologies and digital tools throughout its portfolio companies to support clinical trial …See details»
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio …
Nov 8, 2024 Aditum Bio will fund Oblenio Bio and the parties will collaborate to rapidly bring LBL-051 into clinical studies. Recent clinical data from CD19 and BCMA targeted therapies have …See details»
Values | Aditum Bio | Biotechnology Assets to Benefit Patients
Aditum Bio is a new breed of biotech investment firm that is driven to translate science into the new medicines that make a meaningful difference in the lives of patients. We are a dedicated …See details»